Core Viewpoint - The company plans to acquire significant equity stakes in multiple health management and inspection centers through a share issuance transaction [1][2]. Group 1: Transaction Details - The company intends to purchase 84.00% of Hengyang Meinian Health Examination Center Co., Ltd., 81.00% of Ningde Meinian Health Management Co., Ltd., 75.00% of Yantai Meinian Health Management Co., Ltd., and other varying stakes in several subsidiaries [1]. - The transaction includes acquiring minority stakes in several companies, such as 47.37% in Zhengzhou Meijian Health Management Co., Ltd. and 42.46% in Anhui Meixin Health Management Consulting Co., Ltd. [1]. Group 2: Advisory and Legal Support - The company has engaged several third-party institutions for this transaction, including: - Yuekai Securities Co., Ltd. as the independent financial advisor - Beijing Junzejun Law Offices as the legal advisor - Zhongshun Zhonghuan Accounting Firm as the auditing agency - Jinzhen (Shanghai) Asset Appraisal Co., Ltd. as the evaluation agency [2]. - The company confirms that there are no other direct or indirect third-party institutions or individuals hired for compensation in this transaction [2].

Core Viewpoint - The company has disclosed the differences between the draft report and the restructuring proposal regarding the issuance of shares for asset acquisition and related transactions, highlighting updates and changes in the transaction details and risk factors [1][2][3]. Group 1: Transaction Overview - The restructuring report includes updated definitions and clarifications to aid investor understanding, as well as specific updates to the transaction plan [1]. - The report supplements the performance commitments and compensation arrangements related to the transaction [2]. Group 2: Financial and Operational Information - The report provides additional disclosures on the financial data of the target company, including major financial indicators and recent financial statements [3][4]. - It also includes information on the compliance and integrity of the transaction parties and their management over the past five years [4][5]. Group 3: Risk Factors and Compliance - The report outlines various risks associated with the transaction, including acquisition integration risks and potential dilution of immediate returns [1][6]. - New sections in the report address compliance analysis and management discussions regarding the transaction [6][7]. Group 4: Independent Opinions - The report features updated opinions from independent directors and financial advisors regarding the transaction's fairness and compliance [6][7]. - It also includes statements from legal advisors and audit institutions related to the transaction [6].

美年大健康产业控股股份有限公司 董事会关于本次交易信息公布前 20 个交易日 公司股票价格波动情况的说明 美年大健康产业控股股份有限公司（以下简称"公司"）拟通过发行股份的方 式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德美年 大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00%股 权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管理 有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年健 康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公司 大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理有限 公司 48.05%少数股权（以下简称"本次交易"）。 综上，在剔除大盘因素和同行业板块因素影响后，公司股价在本次重大事项 披露前 20 个交易日内累计涨跌幅未超过 20%，不存在异常波动的情况。 特此说 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-043 第五条 公司住所：江苏省南通市人民 区华舍街道中纺时代大厦 0112 室；邮 东路 218 号；邮政编码：226008 美年大健康产业控股股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 美年大健康产业控股股份有限公司（以下简称"公司"）于 2025 年 7 月 11 日 召开第九届董事会第十次（临时）会议，审议通过《关于修订 <公司章程> 的议案》。 本议案尚需提交公司股东大会审议，同时公司董事会提请股东大会授权公司管理 层负责办理工商变更登记、备案手续等相关事项。具体变更内容以工商登记机关 核准登记内容为准。具体情况如下： 一、《公司章程》具体修订内容 修订前的条款 修订后的条款 第五条 公司住所：浙江省绍兴市柯桥 董 事 会 二〇二五年七月十二日 政编码：312030 第二百零五条 本章程以中文书写，其 第二百零五条 本章程以中文书写，其 他任何语种或不同版本的章程与本章 他任何语种或不同版本的章程与本章 程有歧义时，以在江苏省工商行政管理 程有歧义时，以在浙江省市场监督 ...

美年大健康产业控股股份有限公司 董 事 会 二〇二五年七月十一日 根据《上市规则》，上市公司董事会审议本次交易相关议案时，关联董事已 回避表决；上市公司后续在召开董事会、股东大会审议相关议案时，关联董事、 关联股东将回避表决。 特此说明。 美年大健康产业控股股份有限公司 董事会关于本次交易构成关联交易的说明 美年大健康产业控股股份有限公司（以下简称"上市公司"）拟通过发行股份 的方式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德 美年大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00% 股权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管 理有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年 健康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公司 大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理 ...

Core Viewpoint - The company intends to acquire significant equity stakes in multiple health management and medical examination companies through a share issuance, with a focus on ensuring the independence and fairness of the asset evaluation process [1][2][3] Group 1: Transaction Overview - The company plans to purchase 84% of Hunan Meinian Health Examination Center, 81% of Ningde Meinian Health Management, 75% of Yantai Meinian Health Management, and several other stakes in various health management companies [1] - The total stakes being acquired include significant minority interests in several companies, indicating a broad expansion strategy in the health management sector [1] Group 2: Evaluation Process - The company has engaged Jinzheng (Shanghai) Asset Appraisal Co., Ltd. as the asset evaluation agency, which is compliant with the Securities Law and has the necessary qualifications and experience [2] - The evaluation is based on a reference date of March 31, 2025, and aims to assess the total equity value of the target companies [2] Group 3: Evaluation Independence and Assumptions - The evaluation agency is independent, with no existing relationships or conflicts of interest with the company or the transaction parties, ensuring an unbiased assessment [2] - The assumptions set by the evaluation agency are reasonable and comply with national laws and market practices, reflecting the actual conditions of the assets [2] Group 4: Evaluation Methods and Fairness - The evaluation utilized both the income approach and asset-based approach, ultimately relying on the income approach for the final valuation of the equity [3] - The evaluation process adhered to principles of independence, objectivity, and fairness, resulting in a valuation that accurately reflects the market value of the assets as of the evaluation date [3] - The transaction pricing is based on the evaluation results, ensuring fairness and reasonableness, protecting the interests of the company and its minority shareholders [3]

美年大健康产业控股股份有限公司 第一章 总则 目 录 第一条 为维护美年大健康产业控股股份有限公司（以下简称"公司"）、股东和债权人的 合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》（以下简称《公司 法》）、《中华人民共和国证券法》（以下简称《证券法》）和其他有关规定，制定本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。 公司经国家外经贸部外经贸资二函20011039号文批准，由南通友谊实业有限公司（以下 简称"友谊公司"）、日本三轮株式会社、株式会社飞马日本、上海得鸿科贸有限公司、南通 热电厂将其共同投资的江苏三友集团有限公司（以下简称"三友公司"）依法变更的股份有限 公司。 章 程 （2025年7月修订） 三友公司原有的权利义务均由公司承继。 公司成立时在国家工商行政管理局注册登记，并于2001年11月8日取得了企业法人营业执 照。公司的营业执照号码为：320000400000850。 第三条 公司于2005年4月25日经中国证券监督管理委员会批准，首次向社会公众发行人 民币普通股4500万股。公司公开发行的股份均为向境内投资人发行的以人民币认购的内资股， 于2005 ...

Core Viewpoint - The independent directors of Meinian Onehealth Healthcare Holdings Co., Ltd. have approved a series of proposals regarding the acquisition of equity stakes in multiple companies through a share issuance, which is expected to enhance the company's business structure and profitability [1][2][3]. Group 1: Approval of Proposals - The independent directors have reviewed and approved the proposal for the company to issue shares for asset acquisition, confirming compliance with relevant laws and regulations [1]. - The transaction plan for issuing shares to purchase assets and related party transactions has been deemed reasonable and operable, benefiting the company's business structure and shareholder interests [2]. - The independent directors have also approved the draft report related to the share issuance for asset acquisition, affirming its compliance with legal requirements [2]. Group 2: Transaction Characteristics - The transaction involves acquiring stakes in 11 companies, including Hengyang Meinian Health Checkup Center Co., Ltd., and minority stakes in 5 subsidiaries, including Zhengzhou Meijian Health Management Co., Ltd. [1]. - The transaction is classified as a related party transaction due to the involvement of a company controlled by the actual controller of Meinian [3]. - It has been confirmed that the transaction does not constitute a major asset restructuring as the assets involved do not exceed 50% of the company's relevant financial metrics [4]. Group 3: Compliance and Procedures - The independent directors have confirmed that the transaction adheres to the regulatory requirements for major asset restructuring and does not involve any recent changes in control [4][5]. - The company has fulfilled all necessary legal procedures and submitted valid legal documents for the transaction [7]. - The evaluation agency selected for the transaction has been deemed independent, and the valuation methods used are considered reasonable and fair [7][9]. Group 4: Financial Aspects - The total transaction price for the equity stakes is approximately 427.78 million yuan [9]. - The company has conducted an analysis of the impact of the transaction on immediate returns and has proposed measures to mitigate any potential dilution of returns [8]. Group 5: Authorization and Future Steps - The board of directors has requested authorization from the shareholders' meeting to handle all matters related to the transaction, including adjustments to the transaction plan and execution of necessary agreements [10].

Core Viewpoint - The transaction involving Meinian Health is compliant with the relevant regulations regarding the hiring of third parties in investment banking activities, as confirmed by the independent financial advisor, Yuekai Securities [1][2]. Group 1: Transaction Details - Meinian Health plans to acquire stakes in multiple health management companies, including 84% in Hengyang Meinian Health Checkup Center, 81% in Ningde Meinian Health Management, and 75% in Yantai Meinian Health Management, among others [1]. - The transaction involves acquiring a total of 12 companies with varying ownership percentages, indicating a significant expansion strategy for Meinian Health [1]. Group 2: Compliance and Verification - Yuekai Securities, as the independent financial advisor, conducted a thorough review and found no evidence of Meinian Health hiring third parties for compensation in this transaction, adhering to the guidelines set by the China Securities Regulatory Commission [2]. - The independent financial advisor confirmed that Meinian Health only engaged necessary intermediaries such as financial advisors, legal consultants, auditing firms, and appraisal agencies, in compliance with market practices and regulations [2].

Core Viewpoint - The adjustment of the transaction plan by Meinian Health does not constitute a significant change to the restructuring plan, as confirmed by the independent financial advisor, Guangdong Kai Securities [2][8]. Group 1: Transaction Details - Meinian Health plans to acquire stakes in several health management companies, including 84.00% of Hengyang Meinian, 81.00% of Ningde Meinian, and 75.00% of Yantai Meinian, among others [1][2]. - The transaction involves a total of 14 companies, with varying ownership percentages, including minority stakes in some [1][2]. Group 2: Adjustments to the Transaction Plan - The transaction plan has been adjusted to exclude certain parties and assets, specifically reducing the number of transaction counterparties and the stakes in specific companies [3][4]. - The adjustments include the removal of Chen Xiaoping, Lin Shuping, and Liu Guanghua as transaction counterparties, and the exclusion of stakes in Xiamen Yincheng Meinian, Anxi Meinian, and Nanning Meiyuan Kang [4][8]. Group 3: Compliance with Regulations - The adjustments made to the transaction plan do not exceed the 20% threshold for significant changes as defined by the relevant regulations, thus not requiring a new shareholder meeting for approval [4][8]. - The independent financial advisor has verified that the changes comply with the regulations set forth in the Major Asset Restructuring Management Measures [4][8].